Global Canes And Crutches Market Size and Share
Global Canes And Crutches Market Analysis by Mordor Intelligence
The global canes and crutches market size stood at USD 1.18 billion in 2025 and is expected to reach USD 1.44 billion by 2030, advancing at a 4.17% CAGR over the forecast period. Demand moves steadily from basic walking aids to connected, lightweight devices that fit coordinated care programs and consumer expectations for independent living. Population ageing supplies the deepest demand pool, with the World Health Organization estimating 2.5 billion people in need of assistive products by 2050[1]World Health Organization, “Assistive Products Global Report,” who.int. Technology-ready healthcare systems, new reimbursement codes and rising musculoskeletal disease prevalence further widen the customer base. Materials science has become a strategic factor as carbon-fiber composites cut device weight and enable sensor integration. At the same time, policy makers tighten documentation rules for “low-tech” equipment, forcing suppliers to justify clinical value and accelerate product refresh cycles.
Key Report Takeaways
- By product type, canes led with 55.23% of the canes and crutches market share in 2024, whereas crutches are projected to post the fastest 4.41% CAGR to 2030.
- By material composition, aluminum accounted for 37.46% of revenue in 2024, while carbon-fiber composites are forecast to expand at a 4.51% CAGR through 2030.
- By end user, home-care settings captured 41.14% of the canes and crutches market size in 2024; rehabilitation centers represent the quickest growing end-user segment at a 4.21% CAGR.
- By distribution channel, retail pharmacies held 45.45% revenue share in 2024, but online portals are advancing at a 4.32% CAGR to 2030.
- By geography, North America commanded 40.53% revenue share in 2024; Asia-Pacific is the fastest growing region at a 4.52% CAGR through 2030.
Global Canes And Crutches Market Trends and Insights
Drivers Impact Analysis
Driver | % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Rise in global geriatric population | +1.2% | Global, concentrated in APAC and North America | Long term (≥ 4 years) |
Growing incidence of osteoarthritis & rheumatoid arthritis | +0.8% | Global, higher impact in developed markets | Medium term (2-4 years) |
Rise in rehabilitation & home-health adoption | +0.7% | North America & EU, expanding to APAC | Medium term (2-4 years) |
Smart, sensor-enabled canes & crutches adoption surge | +0.5% | North America & EU early adoption, APAC following | Short term (≤ 2 years) |
Sustainability-driven demand for carbon-fiber aids | +0.3% | Global, led by environmentally conscious markets | Long term (≥ 4 years) |
Hands-free knee-crutch innovations boosting accessory sales | +0.2% | North America & EU, niche market expansion | Short term (≤ 2 years) |
Source: Mordor Intelligence
Rise in Global Geriatric Population
United Nations data show the share of people aged 65 and above rising sharply in the least-developed economies, confirming a prolonged upswing for the canes and crutches market[2]United Nations Department of Economic and Social Affairs, “World Population Prospects,” un.org. Larger elderly cohorts directly translate into higher demand for balance-support aids as well as replacements driven by progressive mobility decline. Asian countries such as Japan face support-ratio drops to 2.4 workers per senior by 2025, tightening caregiver capacity and encouraging uptake of self-help devices. Governments respond with healthy-ageing policies and reimbursement improvements, which together sustain long-range purchasing momentum.
Growing Incidence of Osteoarthritis & Rheumatoid Arthritis
Musculoskeletal disorders push a constant flow of chronic users into the canes and crutches market. These conditions advance gradually, extending device lifecycles and replacement frequency. Non-invasive aids appeal to payers seeking cost avoidance versus surgery, making crutches and canes central to conservative treatment strategies. As younger cohorts experience joint damage owing to sedentary lifestyles and sports stress, addressable demand widens beyond traditional senior demographics.
Rise in Rehabilitation & Home-Health Adoption
Outpatient rehabilitation centers are expanding at a 4.21% CAGR, encouraged by payer moves toward cost-efficient care pathways. Discharged patients take portable walking aids home, boosting follow-on sales of accessories and smart monitoring features. Growth in home-health services aligns with Medicare support for aging-in-place, thereby positioning connected mobility devices as integral components of virtual care plans. Real-time usage data allow therapists to update exercise protocols without clinic visits, improving outcomes and device stickiness.
Smart, Sensor-Enabled Canes & Crutches Adoption Surge
The FDA-cleared EvoWalk 1.0 illustrates how artificial-intelligence and electrical stimulation create therapeutic value that satisfies tighter reimbursement rules evolutiondevices.com. Embedded sensors capture gait symmetry, load distribution and cadence, turning a mechanical aid into a data source for clinicians. Patent applications in self-care technologies filed under the World Intellectual Property Organization confirm commercial confidence in this transformation[3]World Intellectual Property Organization, “Technology Trends for Self-Care in Ageing Societies,” wipo.int.
Restraints Impact Analysis
Restraint | % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Availability of alternative mobility devices | -0.6% | Global, higher impact in developed markets | Medium term (2-4 years) |
Shrinking third-party reimbursement for "low-tech" aids | -0.4% | North America & EU primarily | Short term (≤ 2 years) |
Ergonomic injuries from prolonged axillary-crutch use | -0.2% | Global, clinical awareness driving change | Long term (≥ 4 years) |
Growing preference for robotic exoskeletons | -0.3% | North America & EU early adoption | Long term (≥ 4 years) |
Source: Mordor Intelligence
Availability of Alternative Mobility Devices
Wheelchairs, scooters and walkers present functional substitutes, especially for users whose strength or balance is severely impaired. Medicare’s detailed rules for power mobility equipment make these options financially feasible for specific clinical profiles. Advancing power-assist technology narrows the effort gap further, prompting some consumers to bypass crutches entirely.
Shrinking Third-Party Reimbursement for “Low-Tech” Aids
Centers for Medicare & Medicaid Services introduced new documentation layers and HCPCS codes in 2024, raising administrative hurdles for basic walking aids. Insurers increasingly demand evidence of measurable clinical benefit, a requirement easier to meet for sensor-enhanced products than for conventional wooden canes. Heightened paperwork may delay device issuance and suppress volume growth among price-sensitive groups.
Segment Analysis
The segment held a 55.23% share of the canes and crutches market in 2024, confirming the versatility of single-point, quad and offset designs for users with light to moderate balance issues. Crutches, though smaller in base, are projected to expand at a 4.41% CAGR through 2030 as rehabilitation protocols emphasize early ambulation and as smart crutch prototypes attract technology-savvy clinics. Axillary models risk user fatigue and nerve compression, steering demand toward ergonomic forearm formats. Smart crutches equipped with load sensors and Bluetooth modules transform post-injury care into an evidence-based process, appealing to therapists intent on tracking compliance.
Rising material substitution underpins the product split. Lightweight carbon-fiber shafts improve swing clearance and reduce upper-body strain, boosting adoption among long-term users. Accessory sales such as ice tips, pivoting ferrules and shock-absorbing grips form a recurring-revenue layer that helps manufacturers differentiate beyond commodity frames. Because crutch prescriptions often accompany outpatient surgeries, hospital discharge planners have become a critical gatekeeper for brand choice in the canes and crutches market.
Note: Segment shares of all individual segments available upon report purchase
By Material Composition: Aluminum Dominates, Carbon-Fiber Gains
Aluminum delivered 37.46% revenue in 2024 thanks to its friendly price-performance ratio and established tooling lines. Carbon-fiber, however, represents the fastest growing slice at a 4.51% CAGR. Composite shafts withstand high cyclic loading while weighing less than half of steel counterparts, a benefit that resonates with frail seniors and active rehabilitation patients alike. In addition, carbon-fiber accommodates embedded wiring for sensor arrays without compromising structural integrity, a prerequisite for the next generation of connected aids.
Wood keeps a niche foothold serving users who favor traditional aesthetics, yet its declining share reflects weight, moisture and maintenance drawbacks. Thermoplastic elastomers find roles in tips and ergonomic handles, where slip resistance and vibration dampening gain renewed attention from occupational therapists. As healthcare procurement policies embrace lower life-cycle carbon footprints, recyclable composite resins add a sustainability lever that further propels the canes and crutches market.
By End User: Home-Care Leads, Rehabilitation Centers Outpace
Home-care settings accounted for 41.14% of global revenue in 2024, underscoring consumer preference for aging at home as well as payer initiatives that steer patients away from costlier institutional beds. Here, bundled service models pair a cane or crutch with telehealth check-ins, ensuring adherence and safety. Rehabilitation centers, though smaller today, are expected to grow the quickest at 4.21% CAGR because outpatient therapy volumes surge when hospitals discharge patients sooner.
Hospitals and clinics sustain steady baseline demand, primarily through acute injury and post-operative pathways. Sports medicine facilities add incremental growth by prescribing forearm crutches and smart gait-training sticks to athletes focused on rapid return-to-play protocols. Meanwhile, the canes and crutches industry sees occupational health programs introduce stand-assist sticks on factory floors to reduce slip-and-fall incidents among aging workers.
Note: Segment shares of all individual segments available upon report purchase
By Distribution Channel: Retail Remains Central, Online Accelerates
Retail pharmacies preserved a 45.45% share in 2024 thanks to proximity, inventory breadth and pharmacist guidance. Yet online storefronts post a 4.32% CAGR through 2030 as mobility-restricted consumers value home delivery and peer reviews. E-commerce platforms facilitate subscription offerings for replacement tips and batteries, transforming one-off sales into annuity streams. Hospital pharmacies focus on high-turn crutches tied to surgical departments, while durable medical equipment showrooms increasingly stock carbon-fiber and smart variants to capture upscale demand.
New reimbursements permit electronic document submission, cutting processing time for remote purchases and legitimizing the digital channel. As a result, omni-channel strategies emerge: manufacturers list flagship lines on major marketplaces but steer professional-grade models through clinical portals that bundle training videos and tele-rehab support.
Geography Analysis
North America anchored 40.53% of global revenue in 2024, supported by Medicare and Medicaid policies that subsidize device acquisition and by robust distribution infrastructures. The canes and crutches market size in the region benefits from updated HCPCS codes that standardize billing and facilitate quicker claims processing cms.gov. High technology adoption encourages early uptake of sensor-enabled models, giving suppliers pricing power. Demographic patterns remain a core driver, as the proportion of residents aged 65+ grows each year.
Asia-Pacific is forecast to post the fastest 4.52% CAGR through 2030. Japan’s projected healthcare outlay of ¥89 trillion in 2040 underscores the financial imperative to deploy cost-effective mobility aids for a rapidly greying population. China’s anticipated health spend reaching USD 33.4 trillion by 2060 further expands the prospective customer base. Regional governments invest in community health programs that reimburse basic walking aids, stimulating volume expansion. Local manufacturing clusters in China and India compress lead times and lower landed costs, accelerating penetration of the canes and crutches market.
Europe delivers solid yet slower growth. Harmonized CE-mark processes streamline market entry, while national payers maintain strict evidence requirements that push suppliers toward data-rich smart devices. Sustainability directives favor recyclable materials, accelerating carbon-fiber adoption. In contrast, Middle East & Africa and South America move from nascent to developing stages. Rising disposable incomes and insurance coverage improvements permit gradual uptake, though constrained distribution networks and lower clinician density temper short-term advances.

Competitive Landscape
The canes and crutches market displays moderate fragmentation. The top five brands hold under 40% of global sales, leaving room for regional specialists and niche innovators. Scale advantages reside chiefly in procurement contracts with pharmacy chains and hospital groups. Drive DeVilbiss leverages broad catalogues that cross-sell bathroom safety and wheelchairs, reinforcing channel loyalty. Cardinal Health exploits distribution muscle to secure formulary positions, whereas Medline Industries capitalizes on private-label programs for large health-system accounts.
Strategic movement concentrates on three themes. First, mergers and carve-outs reshape portfolios, as illustrated by Bioventus divesting its Advanced Rehabilitation unit for USD 45 million in October 2024, reallocating capital toward core biologics. Second, digital augmentation rises: Evolution Devices obtained FDA 510(k) clearance for an AI-enabled stimulatory system that attaches to a standard crutch, signalling convergence between mobility aids and therapeutic wearables. Third, supply-chain localisation mitigates tariff risks; several Asian makers set up assembly in Mexico to serve the United States duty-free under USMCA.
Patent filings cluster around sensor arrays, haptic feedback and foldable carbon-fiber frames, hinting at higher intellectual-property intensity. Start-ups pursue direct-to-consumer subscriptions that package maintenance parts and tele-rehab dashboards, chipping at incumbents reliant on dealer networks. Overall, rivalry pivots from commodity pricing to proof of clinical benefit and digital ecosystem integration.
Global Canes And Crutches Industry Leaders
-
Cardinal Health, Inc.
-
Medline Industries, Inc.
-
Drive DeVilbiss Healthcare
-
Invacare Corporation
-
Sunrise Medical
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- October 2024: Bioventus Inc. divested its Advanced Rehabilitation business to Accelmed Partners for USD 45 million, plus up to USD 20 million earn-outs.
- April 2024: Centers for Medicare & Medicaid Services activated new HCPCS codes, including E0152 for battery-powered walkers, tightening documentation for reimbursements.
- February 2024: FDA issued a warning letter to Trexo Robotics Holdings for marketing mobility devices without pre-market clearance, highlighting strict oversight of emerging technologies.
- January 2024: Evolution Devices secured FDA 510(k) clearance for its EvoWalk 1.0 AI-based functional electrical stimulation system.
Global Canes And Crutches Market Report Scope
As per the scope of the report, canes and crutches are used to assist patients with injured or weak legs to balance and allow them to perform daily activities more safely.
The Canes and Crutches Market is segmented by Product Type (Canes (Single canes and Multiple-legged canes), Crutches (Axillary Crutches and Forearm Crutches), and Accessories), Distribution Channel (Hospitals, Online Stores, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product Type | Canes | Single-point Canes | |
Quad / Multiple-leg Canes | |||
Crutches | Axillary Crutches | ||
Forearm Crutches | |||
Hands-free / Smart Crutches | |||
Accessories | |||
By Material Composition | Wood | ||
Aluminum | |||
Carbon-fiber / Composite | |||
Thermoplastic & Others | |||
By End User | Hospitals & Clinics | ||
Home-care Settings | |||
Rehabilitation Centers | |||
Sports Injury Centers | |||
By Distribution Channel | Retail Pharmacies | ||
Hospital Pharmacies | |||
Online | |||
By Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Canes | Single-point Canes |
Quad / Multiple-leg Canes | |
Crutches | Axillary Crutches |
Forearm Crutches | |
Hands-free / Smart Crutches | |
Accessories |
Wood |
Aluminum |
Carbon-fiber / Composite |
Thermoplastic & Others |
Hospitals & Clinics |
Home-care Settings |
Rehabilitation Centers |
Sports Injury Centers |
Retail Pharmacies |
Hospital Pharmacies |
Online |
North America | United States |
Canada | |
Mexico | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South Korea | |
Rest of Asia-Pacific | |
Middle East and Africa | GCC |
South Africa | |
Rest of Middle East and Africa | |
South America | Brazil |
Argentina | |
Rest of South America |
Key Questions Answered in the Report
What is the current value of the canes and crutches market?
The canes and crutches market size reached USD 1.18 billion in 2025 and is forecast to attain USD 1.44 billion by 2030.
Which product segment leads global sales today?
Canes dominate, holding 55.23% of worldwide revenue in 2024.
Which region is expanding the fastest?
Asia-Pacific is projected to grow at a 4.52% CAGR through 2030, driven by rapid population ageing and healthcare modernization.
How are smart technologies influencing future growth?
Sensor-enabled and AI-assisted devices enhance clinical monitoring, satisfy stricter reimbursement rules and are projected to add 0.5 percentage points to the overall CAGR.
What material trend is shaping product innovation?
Carbon-fiber composites, expanding at 4.51% CAGR, reducing weight and permit embedded electronics, boosting user comfort and data-capture capabilities.
Why are reimbursement policies considered a restraint?
New HCPCS documentation requirements raise administrative load and may delay payment for conventional “low-tech” aids, limiting near-term uptake among cost-sensitive users.